PMS-LIDOCAINE VISCOUS 2% LIQUID

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Kupi sada

Svojstava lijeka Svojstava lijeka (SPC)
07-04-2016

Aktivni sastojci:

LIDOCAINE HYDROCHLORIDE

Dostupno od:

PHARMASCIENCE INC

ATC koda:

N01BB02

INN (International ime):

LIDOCAINE

Doziranje:

2%

Farmaceutski oblik:

LIQUID

Sastav:

LIDOCAINE HYDROCHLORIDE 2%

Administracija rute:

DENTAL

Jedinice u paketu:

100,50 ML

Tip recepta:

OTC

Područje terapije:

LOCAL ANESTHETICS

Proizvod sažetak:

Active ingredient group (AIG) number: 0101280001; AHFS:

Status autorizacije:

MARKETED

Datum autorizacije:

1990-12-31

Svojstava lijeka

                                PRESCRIBING INFORMATION
PMS-LIDOCAINE VISCOUS 2%
Lidocaine Hydrochloride Oral Topical Solution, USP
20 mg/mL
Oral Topical Anesthetic
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montreal, Quebec
H4P 2T4
www.pharmascience.com
Date of Revision:
April 6, 2016
Submission Control No: 193450
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 2 of 21 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................8
DRUG INTERACTIONS
....................................................................................................9
DOSAGE AND ADMINISTRATION
..............................................................................11
OVERDOSAGE
................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
............................................................14
STORAGE AND STABILITY
..........................................................................................16
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................16
REFERENCES
..................................................................................................................17
PART III: CONSUMER
INFORMATION...............................................................................18
_ _
_ _
_Prescribing Information ~ pms-LIDOCAINE VISCOUS 2% _
_Page 3 of 21 _
_ _
PMS-LIDOCAINE VISCOUS 
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Svojstava lijeka Svojstava lijeka francuski 15-04-2016

Upozorenja za pretraživanje vezana za ovaj proizvod